Cytrellis is a medical technology startup that operates in the aesthetic devices market. The company is focused on developing and commercializing innovative aesthetic devices that are first in their class. Their primary product is the ellacor® system, a unique and proprietary technology that uses Micro-Coring® to remove sagging skin on a micro-scale. This technology provides aesthetic practitioners with a new way to improve age-related changes in the skin and restore a youthful appearance.

The company's target clients are aesthetic practitioners who are looking for advanced solutions to address skin aging issues. By providing a novel solution to a common problem, Cytrellis is positioning itself as a leader in the aesthetic devices market.

The business model of Cytrellis is based on the development, production, and sale of its proprietary ellacor® system. The company generates revenue by selling these devices to aesthetic practitioners. The potential for recurring revenue also exists in the form of selling replacement parts or upgrades for the system.

In summary, Cytrellis is a promising startup in the aesthetic devices market, offering a unique solution for skin aging problems. Its business model is based on selling its proprietary technology to aesthetic practitioners, providing them with a new tool to improve their services and satisfy their clients' needs.

Keywords: Medical Technology, Aesthetic Devices, Skin Aging, Micro-Coring® Technology, ellacor® System, Aesthetic Practitioners, Innovative Solutions, Proprietary System, Recurring Revenue, Market Leader.